Cell Counting Market Segmented by Instruments, Consumables & Accessories Products Types and Use by Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies
Industry: Healthcare
Published Date: November-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 333
Report ID: PMRREP33176
With the growing burden of infectious as well as chronic diseases around the world, the global market for cell counting is likely to flourish, exhibiting a 9% CAGR from 2022 to 2032. As of the current year, 2022, the market is estimated to reach a valuation of US$ 19.33 Billion, against US$ 8.16 Billion in 2022.
The prevalence of target infectious diseases such as HIV, measles, diphtheria, and chronic illnesses like leukemia, cancer, and other blood disorders is on the rise, increasing the need for cell counting technology around the world. Consequently, the demand for automated cell counters, analyzers, and high-throughput flow cytometers is also on the rise and is figured out to be the main factor influencing the global cell counting market growth.
|
Attributes |
Details |
|
Global Cell Counting Market CAGR (2022-2032) |
9% |
|
Global Cell Counting Market Size (2022) |
US$ 8.16 Billion |
|
Global Cell Counting Market (2032) |
US$ 19.33 Billion |
The deployment of cell counting equipment and supplies was significantly influenced during the Covid-19 pandemic as there was a widespread emergency for the detection of infection and the spread of novel Coronavirus in the initial days. Later too, cell counting technology was more widely used during the pandemic since osteopenia and lymphopenia were thought to be possible COVID-19 markers. As a result, the COVID-19 outbreak had a very significant effect on the expansion of the global cell counting market key trends and opportunities were witnessed.
The growing use of Bio-rad cell counters in several end-use verticals, including research, healthcare, and industrial applications, is responsible for the segment's significant market advantage. Numerous research fields, including cancer biology, immunology, and neurology, are using electronic cell counting devices more often, which presents exponential growth prospects for the global cell counting business sector.
Also during the projection period, biotechnology and the pharmaceutical industries are expected to see exponential growth and are anticipated to boost the demand for cell counting in tandem. For instance, the California Institute for Regenerative Medicine provided funding of nearly US$ Million in 2021 for the Eli and Edythe Broad Center for research in Stem Cell applications and development of regenerative medicines at UCLA.
Moreover, government programs to support cell therapy research are expanding the market's potential possibilities in recent years. Additionally, recent increases in financing for stem cell research in several countries have further expedited the global cell counting market growth.
By the end of 2020, as per the estimates from the WHO update, the number of people living with HIV throughout the world reached close to 37.7 million. The need for manual cell counters and consumables is thus anticipated to rise as infectious illness incidence rise in emerging economies. Therefore, it is anticipated that factors such as the rising incidence of chronic illnesses, expanding technical developments, and new releases in the global cell counting market would propel the industry's expansion through the forecast years.
Automated cell counters that are presently available in the market for sale have made it easier to precisely determine the stem cell viability and nucleated cell content in cord blood or human bone marrow. Fluorescence imaging and other aspects are also being used more often to measure GFP efficiency for transfecting stem cell operations resulting in a very lucrative opportunity for both existing and new healthcare equipment manufacturers entering the global cell counting market.
Additionally, the introduction of innovative items is expected to spur the cell counting market growth in the coming days. For instance, eNuvio introduced a reusable 3D cell culture microplate in 2020. This cutting-edge plate enables researchers to create embryoid bodies, which are a prerequisite for growing bigger organoids or spheroids from stem cells.
Unfortunately, the higher hemocytometer price and disposable cell counter price is expected to hamper the market opportunities for the manufacturers dealing in this particular sector. On the other hand, the higher price of sophisticated cell counting methods and hematology analyzer product recalls are anticipated to restrain the overall global cell counting market trends.
These tools count the cells in a specific culture solution before adding them to the bioreactors or fermenters to produce the desired product. Over the upcoming years, it is projected that any constraint in the production and sourcing of such biologics created by bioprocessing in these bioreactors or fermenters would pose a major challenge to the adoption of cell counting techniques.
As per the analysis, by component segment, the consumable and accessories segment contributes the dominating market share that translates up to more than 50% of the total revenue generated globally.
Reagents, microplates Instruments magnetic beads, and chamber slides are some of the consumables and accessories utilized with these gadgets and are the highest contributing sub-segment. Their high usage volume is a contributing factor in the expansion of consumables and accessories as well.
Over the projection period, the instruments section is also anticipated to keep a sizeable share in terms of value.
Based on application, as per the previous global cell counting market survey reports, the whole blood count segment had the highest share of more than 55% of the total revenue generated every year. Several blood components are measured by this test which makes it one of the most common and frequent tests performed to assess a person's general health.
So growing prevalence of blood illnesses, including leukemia and anemia, which are frequently monitored by complete blood counts, is anticipated to fuel the expansion of this global cell counting market segment further in the coming days.
On the other hand, during the projection period, the stem cell research application segment is predicted to grow at the quickest CAGR. The necessity for large manufacturing of stem cells from humans for medical and scientific purposes is increasing, which is causing this exponential expansion. In areas like transplantation, cancer treatment, and tissue regeneration medicine, stem cells are absolutely essential.
How will the United States Shape Global Cell Counting Market Growth?
As per the analysis, due to the growing emphasis on biomedical and cancer research, North America held the greatest revenue share of the global cell counting market at about 35% in the previous years. The United States holds the lion's share in sales and use of cell counting machines in this region. Among many of the key factors influencing the use of such types of devices is the growth in the incidence of chronic illnesses, also including blood plasma and cardiovascular disorders.
Also, an increase in the number of elderly patient clinical tests performed each year has led to an unparalleled pace of growth in the sales of cell counting devices in the United States. Similar growth prospects are also poised to favor the regional cell counting market in Canada as well.
What Prospects are in Store for the Global Cell Counting Market in Europe?
Due to robust healthcare infrastructure in all the major European economies, the demand for cell counting technology is quite lucrative for the regional market players. An increasing proportion of the geriatric population and emphasis on medical tourism in several countries is also predicted to expand the cell counting market opportunities in the coming days.
Furthermore, the continent's market is primarily driven by the aging geriatric population, which is extremely sensitive to chronic ailments. In the region, the U.K is anticipated to be a lucrative market during the forecast period.
Will South Korea contribute to a Lucrative Global Cell Counting Market Share?
During the predicted period, Asia Pacific economies are anticipated to increase exponentially with the growing concentration of clinical research and biopharmaceutical businesses in several regions. So the higher domestic demand for cell counting devices and the strengthening of export potential can be blamed for the tremendous growth opportunities in the South Korean cell counting market.
What are the Growth Prospects for the Global Cell Counting Market in Japan?
In recent years Japan has emerged to be a major hub for manufacturing and exporting country of electronics equipment and gadgets. In line with this development, many electronic cell counter manufacturers have reoriented their business strategy to cater to the demand in other countries of Asia Pacific and beyond. Such a market trend is expected to create a huge opportunity for many regional market players and swell the Japan cell counting market.
Key players in the global cell counting market are ThermoFisher Scientific, Inc., Merck KGaA, Agilent Technologies, PerkinElmer, Inc., BD, Danaher, Bio-Rad Laboratories, Inc., BioTek Instruments, Inc., GE Healthcare, and DeNovix Inc. among others.
Further to that, because of their broad range of uses and the simplicity of cell counting protocol, electronic cell counter devices are becoming more and more popular among major industry competitors. For instance, Product improvements such as countess automated cell counter are expected to increase acceptance, which might strengthen the global cell counting market during the projected years.
Additionally, technical developments in cell counting equipment and consumables have enhanced product introductions and, therefore, acceptance, which has, in turn, fueled the global cell counting market expansion. For instance, Portable point-of-care (POC) CD4 T-cell counting devices were created recently with the aim of enhancing low-income countries' access to cheap HIV+ patient monitoring.
Recent developments in the Global Cell Counting market industry include
|
Attributes |
Details |
|
Forecast Period |
2022 to 2032 |
|
Historical Data Available For |
2015 to 2021 |
|
Market Analysis |
US$ Million for Value |
|
Key Countries Covered |
|
|
By Market Segments |
|
|
Key Companies Profiled |
|
|
Pricing |
Available Upon Request |
Global Cell Counting Market by Product
Global Cell Counting Market by Application
Global Cell Counting by End User
Global Cell Counting Market by Region
To know more about delivery timeline for this report Contact Sales
The global cell counting market is likely to witness 9% growth rate through 2032
The global cell counting market is expected to garner US$ 19.33 Billion by 2032
US contributes for more than 35% of the global cell counting market size.
The global cell counting market is estimated to be around US$ 8.16 Billion in 2022.
The whole blood count segment contributes more than 35% of the global cell counting market.
